InvestSMART

Percheron Therapeutics Limited (ASX: PER) - Announcements

- Current share price for PER : $0.003

ASX company news and announcements for Percheron Therapeutics Limited (PER) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Percheron Therapeutics Limited (PER) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Percheron Therapeutics Limited (PER), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Percheron Therapeutics Limited (PER)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Listing Rule waiver to allow quotation of PERAQ options 30 Oct 2026 9:11AM $0.003 $0.003 fallen by 0%
$6 Completion of HMBD-002 Drug Product Manufacture 23 Oct 2026 9:46AM $0.004 $0.003 fallen by 25%
$6 Quarterly Activities Report and Appendix 4C 20 Oct 2026 11:15AM $0.003 $0.003 fallen by 0%
$6 IVX: Photosoft & Novel Immunotherapy Collab Partnership 20 Oct 2026 8:42AM $0.003 $0.003 fallen by 0%
$6 Percheron and Invion to Explore Cancer Combination Therapy 20 Oct 2026 8:23AM $0.003 $0.003 fallen by 0%
$6 Change of Director's Interest Notice 15 Oct 2026 9:36AM $0.004 $0.003 fallen by 14.29%
$6 Notice under S708A 15 Oct 2026 8:17AM $0.004 $0.003 fallen by 14.29%
$6 Application for quotation of securities - PER 14 Oct 2026 9:29AM $0.004 $0.003 fallen by 25%
$6 Application for quotation of securities - PER 14 Oct 2026 9:20AM $0.004 $0.003 fallen by 25%
$6 Change of Director's Interest Notice 8 Oct 2026 1:12PM $0.004 $0.003 fallen by 14.29%
$6 Notification regarding unquoted securities - PER 8 Oct 2026 1:09PM $0.004 $0.003 fallen by 14.29%
$6 Results of Annual General Meeting 7 Oct 2026 3:40PM $0.004 $0.003 fallen by 25%
$6 Annual General Meeting - Management Presentation 7 Oct 2026 9:47AM $0.004 $0.003 fallen by 25%
$6 Annual General Meeting - Chair Address 7 Oct 2026 9:43AM $0.004 $0.003 fallen by 25%
$6 Proposed issue of securities - PER 5 Oct 2026 5:03PM $0.004 $0.003 fallen by 25%
$6 Final Director's Interest Notice 5 Oct 2026 8:24AM $0.004 $0.003 fallen by 25%
$6 Initial Director's Interest Notice 5 Oct 2026 8:24AM $0.004 $0.003 fallen by 25%
$6 Dr Michael Baker Commences as CEO and MD 5 Oct 2026 8:21AM $0.004 $0.003 fallen by 25%
$6 Notice under S708A 8 Sep 2026 8:36AM $0.006 $0.003 fallen by 50%
$6 Application for quotation of securities - PER 7 Sep 2026 8:25AM $0.005 $0.003 fallen by 40%
$6 2026 Notice of Annual General Meeting 7 Sep 2026 8:24AM $0.005 $0.003 fallen by 40%
$6 Percheron Therapeutics Limited Corporate Presentation 1 Sep 2026 11:01AM $0.006 $0.003 fallen by 50%
$6 Proposed issue of securities - PER 1 Sep 2026 9:23AM $0.005 $0.003 fallen by 40%
$6 Proposed issue of securities - PER 1 Sep 2026 9:23AM $0.005 $0.003 fallen by 40%
$6 Proposed issue of securities - PER 1 Sep 2026 9:23AM $0.005 $0.003 fallen by 40%

1 - 25 of 218 results

Page 1 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.